ABVD Regimen: — Drugs, Cycles and Side Effects
ABVD is the chemotherapy regimen most commonly used for Hodgkin lymphoma. If the letters on your treatment plan have not been explained to you, this page covers what each drug does, how many cycles to expect, and one specific caution about bleomycin that matters well beyond the end of treatment.
- Four drugs, one acronym — ABVD stands for doxorubicin, bleomycin, vinblastine and dacarbazine.
- Treatment runs in cycles — Each cycle lasts about four weeks and involves two infusion appointments. The total number of cycles depends on your stage.
- Bleomycin has a lung risk — Bleomycin can affect lung tissue during and after treatment — and you will need to disclose it to doctors and surgeons for the rest of your life.
- Most side effects are temporary — Nausea, hair loss and fatigue resolve after treatment ends. The bleomycin lung disclosure is the one long-term habit this regimen requires.
Medically reviewed by Dr. N. Kiranmayee, Medical Oncologist · Last reviewed September 2026
ABVD is a four-drug chemotherapy regimen for Hodgkin lymphoma. The drugs are doxorubicin, bleomycin, vinblastine and dacarbazine. Treatment typically runs over 4 to 6 cycles. Bleomycin carries a specific lung risk that requires monitoring during treatment and lifelong disclosure to any doctor — including surgeons — who treats you in future.
What are the four drugs in ABVD?
Doxorubicin — the A (Adriamycin)
Doxorubicin damages the DNA of cancer cells to stop them dividing. It is also known by the brand name Adriamycin, which is where the A in ABVD comes from. The main concern with doxorubicin is its effect on the heart muscle, which is why cardiac function is checked before treatment starts and monitored during it.
Bleomycin — the B
Bleomycin causes breaks in cancer cell DNA. It is the drug in ABVD most closely associated with lung toxicity — a risk your team monitors actively during treatment. If you develop a new dry cough or feel shorter of breath than usual, report it before your next scheduled appointment rather than waiting.
Vinblastine — the V
Vinblastine belongs to a group of drugs called vinca alkaloids. It disrupts the process by which cancer cells divide. It can lower blood counts and cause tingling or numbness in the hands and feet. Tell your team if numbness develops — it is relevant information for decisions about the rest of your treatment.
Dacarbazine — the D
Dacarbazine is an alkylating agent that interferes with cancer cell DNA. It commonly causes nausea on infusion days and the day after. Anti-sickness medicine is prescribed alongside it for this reason. It also reduces blood counts in the days following each infusion.
How many cycles of ABVD will you have?
ABVD is given in cycles, each lasting about four weeks. Each cycle involves two infusion appointments — one at the start of the cycle and one roughly halfway through.
The total number of cycles depends on the stage of your Hodgkin lymphoma. NCCN and ESMO guidelines describe typical ranges from around 4 cycles for earlier-stage disease to 6 cycles for more advanced disease. Your oncologist will set the plan for your specific case.
Partway through treatment, a PET-CT scan is typically done to assess how the lymphoma is responding. The result of that scan informs decisions about the rest of the course. Being called for this scan is planned — it is not a sign that something has gone wrong.
Who is ABVD not suitable for?
ABVD is not appropriate for all patients, even those with Hodgkin lymphoma. Eligibility is determined by an oncologist based on individual staging, organ function tests, and overall health.
ABVD is generally not used in the following situations:
- Significant pre-existing lung disease — bleomycin can worsen lung function, making it unsafe for patients with already reduced respiratory capacity.
- Significantly reduced heart function — doxorubicin has a cumulative effect on the heart muscle, and baseline cardiac function must support its use.
- Non-Hodgkin lymphomas — ABVD is not a standard regimen for these conditions; different drug combinations are used.
- Active serious infection or severely impaired organ function — these affect whether each component drug can be given safely.
Where one of these concerns applies, an alternative regimen may be considered. Only an oncologist can determine whether ABVD is appropriate for a specific individual.
What is the bleomycin lung risk?
Bleomycin can inflame and scar lung tissue — a condition called bleomycin-induced pulmonary toxicity. It can develop during treatment or in the months after it ends.
Symptoms to report immediately include a new dry cough, shortness of breath during ordinary activity, and reduced exercise tolerance. These are distinct from general chemotherapy fatigue and should be reported to your team promptly, not held over for a scheduled visit.
Lung function tests are commonly done before ABVD starts and may be repeated during treatment. Your oncologist may pause or stop bleomycin if there are early signs of lung involvement.
Because Hodgkin lymphoma often affects younger people, this risk carries particular long-term significance. If you ever need surgery or a general anaesthetic in future — even years after finishing treatment — tell every doctor and anaesthesiologist that you received bleomycin. High oxygen concentrations given during surgery can trigger or worsen bleomycin lung damage. Ask your oncology team for a written treatment summary to keep with your records.
What other side effects should you tell your team about?
Nausea is common on infusion days and the following day. Use the anti-sickness medicines your team prescribes rather than waiting to see how you feel — they work better taken as directed than used after nausea has already started.
Hair loss is temporary. It usually begins within the first few weeks of treatment and returns after treatment ends. The texture may differ initially. Knowing this in advance — and discussing it with your team before you start — tends to make it easier to manage.
ABVD lowers blood counts, raising the risk of infection. Any fever during treatment is a reason to call your team the same day. Out of hours, go to the emergency department and tell them you are receiving chemotherapy — this is assessed urgently and should not wait.
Fatigue tends to accumulate across cycles rather than peaking immediately after each infusion. Planning lighter commitments in the days after treatment helps. Most people find that pacing matters more than rest, and that this becomes clearer after the first couple of cycles.
Explore 82 more How Chemotherapy Is Given: Regimens, Cycles & Infusion Days topics
Chemotherapy Regimens by Name
- 7+3 and Induction Regimens for Acute Leukaemia
- ABVD Regimen for Hodgkin Lymphoma
- AC and EC Regimens
- AC-T Regimen for Breast Cancer
- BEP Regimen for Testicular and Germ Cell Cancer
- CAPOX and XELOX Regimens
- CHOP Without Rituximab
- Carboplatin-Paclitaxel Regimen
- Cervical Cancer Chemotherapy and Chemoradiation Regimens
- Chemotherapy Regimens: What the Acronyms Mean
- Cisplatin-Pemetrexed and Platinum-Pemetrexed
- Comparing Two Regimens: How the Choice Is Made
- DCF and FLOT Regimens for Stomach Cancer
- Doxorubicin-Ifosfamide and Sarcoma Regimens
- EP and Carboplatin-Etoposide for Small Cell Lung Cancer
- FEC and CMF Regimens
- FOLFIRI Regimen
- FOLFIRINOX and Modified FOLFIRINOX
- FOLFOX Regimen for Colorectal Cancer
- GemCis and MVAC for Bladder Cancer
- Gemcitabine-Nab-Paclitaxel for Pancreatic Cancer
- R-CHOP Regimen for Lymphoma
- Salvage Lymphoma Regimens: ICE, DHAP and ESHAP
- TC Regimen (Docetaxel and Cyclophosphamide)
- TPF and Cisplatin Regimens for Head and Neck Cancer
- VRd, VCd and Myeloma Regimens
- Weekly Cisplatin With Radiation (Chemoradiation)
- Which Regimen Is Used for Which Cancer?
Cycle Delays, Dose Reductions & Changes
- Does a Delay Mean the Cancer Is Growing?
- Does a Reduced Dose Still Work?
- Growth Factor Support to Keep the Schedule
- How Many Delays Are Too Many?
- Infection Delaying a Cycle
- My Counts Were Too Low and the Cycle Was Postponed
- Organ Function Problems Delaying a Cycle
- Stopping Early: What Happens If You Do Not Complete the Course?
- Transfusion During Chemotherapy
- What If I Cannot Tolerate the Treatment?
- What Is a Dose Reduction and Why Was Mine Reduced?
- What to Ask If Your Plan Changes
- Why Chemotherapy Gets Delayed or Reduced
- Why Was My Regimen Switched?
HUB — Chemotherapy Regimens
HUB — Cycles, Schedules and What Happens on Infusion Day
How Chemotherapy Is Given
- Can Chemotherapy Be Given at Home?
- Can Chemotherapy Be Given at a Local Hospital?
- Continuous Infusion Chemotherapy and Portable Pumps
- Day Care vs Admission for Chemotherapy
- How Is Chemotherapy Given? All the Routes Explained
- How Long Does Each Chemotherapy Session Take?
- Intra-Arterial and Regional Chemotherapy
- Intraperitoneal Chemotherapy
- Intrathecal Chemotherapy: Into the Spinal Fluid
- Intravenous Chemotherapy: What the Drip Involves
- Intravesical Chemotherapy for the Bladder
- Is Oral Chemotherapy Weaker Than Injections?
- Oral Chemotherapy: Tablets Instead of a Drip
- Subcutaneous and Intramuscular Chemotherapy
- Topical Chemotherapy Creams
- What Safety Checks Happen Before Each Dose?
- Who Actually Gives Your Chemotherapy?
- Why Does the Route Sometimes Change During Treatment?
Regimens, Cycles & Schedules
- A Printable Chemotherapy Cycle Calendar
- Adding or Removing Cycles Mid-Course
- Blood Tests Before Every Cycle: What They Check
- Day 1, Day 8, Day 15: What the Day Numbers Mean
- Does Delaying a Cycle Reduce the Benefit?
- How Many Cycles Before the First Assessment?
- How the Dose Is Calculated for You
- Keeping a Chemotherapy Symptom Diary
- Planning Your Life Around Chemotherapy Cycles
- Rescheduling or Missing a Chemotherapy Appointment
- Weekly, Two-Weekly and Three-Weekly Schedules
- What Happens Between Cycles?
- What Happens at the Last Cycle?
- What Is Dose Intensity?
- What Is a Chemotherapy Cycle?
- What Is the Nadir and Why Does It Matter?
- Which Days of the Cycle Will I Feel Worst?
- Why Was My Cycle Postponed?
The Infusion Day
Your First Cycle
All How Chemotherapy Is Given: Regimens, Cycles & Infusion Days →
Frequently asked questions
Does ABVD cause permanent hair loss?
Hair loss with ABVD is temporary. It generally begins within the first few weeks as the drugs affect fast-dividing cells, including those in hair follicles, and it returns after treatment ends. Texture and thickness at regrowth can differ at first but usually normalise. If the prospect of hair loss is distressing — and it often is — raising it with your team before treatment starts means you can discuss options such as cold capping, if it is available at your centre.
Why do I need to tell future doctors about bleomycin even after I finish treatment?
Bleomycin changes how lung tissue responds to high concentrations of oxygen. This sensitivity does not reliably resolve after treatment ends, which means any surgeon or anaesthesiologist treating you in future — even many years later — needs to know about it before planning a procedure. Elevated oxygen given during surgery can trigger or worsen bleomycin lung damage in people who received it, sometimes severely. Ask your oncology team for a written treatment summary listing the drugs you received, and keep it with your medical records.
What should I do if I develop a cough or breathlessness during treatment?
Report it to your oncology team the same day, rather than waiting for your next scheduled appointment. A new dry cough or shortness of breath during ABVD is a specific signal that needs assessment, because it can indicate bleomycin affecting the lung. It may turn out to be unrelated — a viral infection, for instance — but that distinction is one your team needs to make, not one to wait on. Early reporting is what keeps the available management options open.
What is the PET-CT scan done during ABVD treatment?
A PET-CT uses a radioactive tracer to show which areas of the body have metabolically active tissue, including lymphoma. The scan done partway through ABVD — sometimes called an interim PET — assesses how the lymphoma is responding before the full course is complete. The result can inform decisions about the remaining cycles. This scan is a planned part of treatment, not a response to a problem; being called for it does not mean something unexpected has happened.
Can I work during ABVD chemotherapy?
Many people continue working, at least partly, during ABVD, though it depends on the nature of the work, the commute, and individual tolerance of each cycle. The day of infusion and the following day tend to be the most difficult for nausea and fatigue. Work involving physical effort or close contact with many people — because of infection risk — may need to be adjusted more than desk-based or remote work. Discuss your specific situation with your oncologist, who can advise based on your blood count pattern and how you are responding.
How long do ABVD side effects last after the last cycle?
Most side effects begin to resolve once treatment ends. Nausea typically settles quickly. Hair returns within a few months, though the timeline varies. Fatigue is often the most persistent — many people find it takes several months to return to their usual energy levels, and recovery tends to be gradual rather than sudden. The bleomycin lung risk is different: it does not follow the same recovery curve, and the need to disclose it to future healthcare providers does not have an expiry date.
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Where to find us
Our centres in and around Hyderabad
Addressed by landmark, because that is how this city navigates. Each centre also names the areas it serves, so you can place it without a map. Consultation and day-care Chemotherapy run at every one of them.
Chemotherapy Topics
Browse our complete chemotherapy guide — 1133 pages on side effects, medicines, cost, daily life and care in Hyderabad. Tap any topic to read more.